Table 2.
Genes in ADHD CNVs previously associated with neuropsychiatric and neurological disorders
Gene | Disorder(s)a | Genomic reference(s)b |
---|---|---|
A2BP1 | Schizophrenia; autism; mental retardation | (15, 21, 55, 56) |
APOL4 | Schizophrenia | (57) |
ATM | Ataxia-telangiectasia; neurodegeneration | (58, 59) |
AUTS2 | Mental retardation and autism | (60–62) |
BLMH | Alzheimer's disease | (63) |
CHL1 | Schizophrenia | (64) |
CHN2 | Schizophrenia | (65) |
CNTNAP2 | Schizophrenia; autism; Tourette syndrome | (17, 58, 66–68) |
CPLX2 | Schizophrenia | (69) |
CTNND2 | Mental retardation in cri du chat syndrome | (70) |
DPP6 | Schizophrenia | (21) |
GRM5 | Schizophrenia; Fragile X syndrome | (71, 72) |
GRM7 | Schizophrenia | (19) |
IMMP2L | Autism; Tourette syndrome | (73–76) |
NKAIN2 | Schizophrenia | (21) |
PARK2 | Schizophrenia | (21) |
PDCD10 | Cerebral cavernous malformations | (77) |
PTPRD | Restless legs syndrome | (33) |
RTN4 | Schizophrenia | (78) |
SEPP1 | Schizophrenia | (79) |
SERPINI1 | Schizophrenia | (80, 81) |
TACR3 | Schizophrenia | (82) |
Abbreviations: ADHD, attention-deficit/hyperactivity disorder; CNVs, copy number variations.
Underlined disorders indicate implication through CNV analysis.
References in Table 2 are listed in the Supplementary Materials.